Clinical Trials

Keywords/SWOG Study Number

Area of Research

Accrual Status

Any

Open

Closed

Limit to SWOG Trials

All Trials

SWOG Trials Only

Show only published studies

Study Type

Treatment

Study Chair

Participating Institution

Phase

Cancer Control Subcommittee

Study Sponsor

FDA Registration Trial

Uses PRO Forms

1032 Results

View

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8835

Intraperitoneal Mitoxantrone vs. Intraperitoneal FUdR for Ovarian Cancer Patients with Minimal Residual Disease after Second-Look Surgery, A Randomized Phase II Pilot

Research Committee(s)

Gynecologic Cancer

Activated

12-01-1988

Closed

01-01-1994

Closed

Phase

Accrual

65%

Published

SWOG Clinical Trial Number

SWOG-8795 (INT-0094) (EST-1888)

Randomized Prospective Comparison of Bacillus Calmette-Guerin and Mitomycin-C Therapy and Prophylaxis in Superficial Transitional Cell Carcinoma of the Bladder with DNA Flow Cytometric Analysis

Research Committee(s)

Genitourinary Cancer

Activated

12-01-1988

Closed

05-15-1992

Closed

Phase

Accrual

87%

Published

SWOG Clinical Trial Number

SWOG-8719

Evaluations of Didemnin B or Ifosfamide/Mesna in Endocrine Resistant Prostate Cancer and of Ifosfamide/Mesna in Patients without Prior Endocrine Manipulation

Research Committee(s)

Genitourinary Cancer

Activated

11-01-1988

Closed

05-15-1993

Closed

Phase

Accrual

66%

Published

SWOG Clinical Trial Number

SWOG-8614

Temporarily Closed: 4/15/90, Chemotherapy of Gastric Cancer with VM-26

Activated

10-15-1988

Closed

09-15-1990

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8809

A Phase III Study of Alpha-Interferon Consolidation Following Intensive Chemotherapy with ProMACE- MOPP (Day 1-8) in Patients with Low Grade Malignant Lymphomas

Research Committee(s)

Lymphoma

Activated

10-01-1988

Closed

11-15-1994

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8801

A Study of the Sequential Combination of Recombinant Interferon Gamma (rIFN-y) and Recombinant Interleukin-2 (rIL-2) in Patients with Disseminated Malignant Disease

Activated

10-01-1988

Closed

01-01-1990

Closed

Phase

Accrual

90%

Published

SWOG Clinical Trial Number

SWOG-8609

VM-26 (Teniposide) Single Drug Treatment for Extensive Small Cell Lung Cancer

Research Committee(s)

Lung Cancer

Activated

09-15-1988

Closed

11-15-1990

Closed

Phase

Accrual

17%

SWOG Clinical Trial Number

SWOG-8752

A Phase II Study of Recombinant Tumor Necrosis (rTNF) in Patients with Endometrial Cancer

Activated

09-15-1988

Closed

07-15-1990

Closed

Phase

Accrual

63%

Published

SWOG Clinical Trial Number

SWOG-8741

A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Refractory Carcinoma of the Breast

Activated

09-15-1988

Closed

11-15-1990

Closed

Phase

Accrual

77%

Published

SWOG Clinical Trial Number

SWOG-8811

Phase II Trial of 5-Fluorouracil and High Dose Folinic Acid as First or Second Line Therapy for Advanced Breast Cancer

Activated

09-01-1988

Closed

11-15-1990

Closed

Phase

Accrual

SWOG Clinical Trial Number

SWOG-8610

Prospective Randomized Clinical Trial of the Capillary Cloning System for Patients with Extensive Small-Cell Lung Cancer

Activated

09-01-1988

Closed

11-01-1989

Closed

Phase

Accrual

67%

Published

SWOG Clinical Trial Number

SWOG-8746

Phase I Trial of Dose Intensive Chemotherapy Combined with Granulocyte-Macrophage Colony Stimulating Factor in Advanced Breast Cancer

Activated

09-01-1988

Closed

09-01-1992

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8737

Phase III AZQ 24-hour Infusion versus BCNU for Adult High Grade Gliomas

Activated

08-15-1988

Closed

05-15-1991

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8794

Treatment of Pathologic Stage C Carcinoma of the Prostate with Adjuvant Radiotherapy

Research Committee(s)

Genitourinary Cancer

Activated

08-15-1988

Closed

01-01-1997

Closed

Phase

Accrual

25%

SWOG Clinical Trial Number

SWOG-8806

A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Advanced Bladder Cancer (for patients not eligible for SWOG-8594)

Activated

08-15-1988

Closed

11-15-1990

Closed

Phase

Accrual

72%

Published

SWOG Clinical Trial Number

SWOG-8850

Cisplatin and Novobiocin in the Treatment of Stage IV, Stage IIIb or Locally Recurrent Tumor After Radiation Therapy of Non-Small Cell Lung Cancer (NSCLC)

Activated

08-15-1988

Closed

06-01-1990

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-8500

Second-Line Treatment of Advanced Measurable Ovarian Cancer with CHIP

Activated

08-01-1988

Closed

11-15-1988

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-8742

Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Metastatic Sarcoma

Activated

08-01-1988

Closed

12-01-1989

Closed

Phase

Accrual

27%

SWOG Clinical Trial Number

SWOG-8744

A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Refractory Multiple Myeloma

Activated

08-01-1988

Closed

11-15-1990

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-8723

Evaluation of Amonafide in Disseminated Malignant Melanoma

Activated

07-15-1988

Closed

06-01-1990